MedMira Inc. (MMIRF)
MMIRF Stock Price Chart
Explore MedMira Inc. interactive price chart. Choose custom timeframes to analyze MMIRF price movements and trends.
MMIRF Company Profile
Discover essential business fundamentals and corporate details for MedMira Inc. (MMIRF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
3 Nov 2009
Employees
—
Website
https://www.medmira.comCEO
Hermes Chan
Description
MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally. The company offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product to perform preliminary screening of HIV and hepatitis. It also provides Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics; and Reveal HP, a rapid H. Pylori antibody test, which detects helicobacter pylori (HP) antibodies in serum, plasma, or whole blood produced in response to HP infection. In addition, the company offers VYRA CoV2 that detects antigens specific for the nucleocapsid region of SARS-CoV-2; VYRA CoV2Flu, a combination viral nucleocapsid antigen tests that detects infection caused by SARS-CoV-2, and Influenza A and Influenza B; and REVEALCOVID-19, an antibody test. It sells its products through a network of medical distributors and strategic business development partners to customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
MMIRF Financial Timeline
Browse a chronological timeline of MedMira Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Mar 2026
Upcoming earnings on 26 Nov 2025
Earnings released on 1 Jul 2025
EPS came in at -$0.00 , while revenue for the quarter reached $42.82K .
Earnings released on 1 Apr 2025
EPS came in at -$0.00 , while revenue for the quarter reached $46.79K .
Earnings released on 27 Dec 2024
EPS came in at -$0.00 , while revenue for the quarter reached $44.34K .
Earnings released on 29 Nov 2024
EPS came in at -$0.00 , while revenue for the quarter reached $46.45K .
Earnings released on 3 Jul 2024
EPS came in at -$0.00 , while revenue for the quarter reached $59.65K .
Earnings released on 2 Apr 2024
EPS came in at -$0.00 , while revenue for the quarter reached $110.64K .
Earnings released on 29 Dec 2023
EPS came in at -$0.00 , while revenue for the quarter reached $85.61K .
Earnings released on 28 Nov 2023
EPS came in at -$0.00 , while revenue for the quarter reached $26.37K .
Earnings released on 30 Jun 2023
EPS came in at -$0.00 , while revenue for the quarter reached $77.97K .
Earnings released on 4 Apr 2023
EPS came in at -$0.00 , while revenue for the quarter reached $127.73K .
Earnings released on 31 Dec 2022
EPS came in at -$0.00 , while revenue for the quarter reached $88.54K .
Earnings released on 30 Nov 2022
EPS came in at -$0.00 , while revenue for the quarter reached $100.18K .
Earnings released on 30 Apr 2022
EPS came in at -$0.00 , while revenue for the quarter reached $252.38K .
Earnings released on 31 Mar 2022
EPS came in at -$0.00 , while revenue for the quarter reached $234.31K .
Earnings released on 30 Dec 2021
EPS came in at -$0.00 , while revenue for the quarter reached $88.24K .
Earnings released on 31 Oct 2021
EPS came in at -$0.00 , while revenue for the quarter reached $163.42K .
Earnings released on 30 Apr 2021
EPS came in at -$0.00 , while revenue for the quarter reached $68.11K .
Earnings released on 31 Mar 2021
EPS came in at $0.00 , while revenue for the quarter reached $1.21M .
Earnings released on 31 Jan 2021
EPS came in at -$0.00 , while revenue for the quarter reached $271.35K .
MMIRF Stock Performance
Access detailed MMIRF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.